Evvy combines at-home vaginal microbiome testing with clinician-reviewed results, personalized next steps and optional treatment and coaching for women’s health.
Catalio Capital Management
Activity from announced rounds
Catalio Capital Management is an investment manager whose official company communications identify BigHat Biosciences and Basecamp Research.
Recorded funding activity
BigHat combines AI and synthetic biology to engineer antibody therapeutics. Basecamp builds biological models from genomic data for therapeutic design, while Enveda discovers biologically active molecules from nature. The financings represent different routes from biological data to experimental medicines.
Sources
- Rounds participated in
- 5
- Confirmed lead rounds
- 1 4 roles undisclosed
- New companies
- 5 First participation on record · 0 follow-on
- Funding in participating rounds
- $519M 5 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
5 in this selectionAdvanCell develops targeted alpha radiopharmaceuticals for cancer using Lead-212, with integrated isotope supply and manufacturing.
AI-enabled virtual specialty care platform for managing high-cost chronic conditions
Develops treatments for patients suffering from thromboembolic disease
Provides non-CPAP alternative for Obstructive Sleep Apnea treatment